These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 15688388

  • 41. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial.
    Siebers AG, Klinkhamer PJ, Grefte JM, Massuger LF, Vedder JE, Beijers-Broos A, Bulten J, Arbyn M.
    JAMA; 2009 Oct 28; 302(16):1757-64. PubMed ID: 19861667
    [Abstract] [Full Text] [Related]

  • 42. CareHPV cervical cancer screening demonstration in a rural population of north India.
    Labani S, Asthana S, Sodhani P, Gupta S, Bhambhani S, Pooja B, Lim J, Jeronimo J.
    Eur J Obstet Gynecol Reprod Biol; 2014 May 28; 176():75-9. PubMed ID: 24685404
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Increased frequency of abnormal Papanicolaou smears in adolescents.
    Silva CS, Souza MA, Angelo AG, Pavani R, Adad SJ, Murta EF.
    Arch Gynecol Obstet; 2002 Jul 28; 266(3):154-6. PubMed ID: 12197555
    [Abstract] [Full Text] [Related]

  • 46. Test positivity cutoff level of a high risk human papillomavirus test could be increased in routine cervical cancer screening.
    Kotaniemi-Talonen L, Malila N, Nieminen P, Anttila A, Tarkkanen J, Laurila P, Hakama M.
    Int J Cancer; 2008 Dec 15; 123(12):2902-6. PubMed ID: 18792100
    [Abstract] [Full Text] [Related]

  • 47. A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California.
    Hammer A, Demarco M, Campos N, Befano B, Gravitt PE, Cheung L, Lorey TS, Poitras N, Kinney W, Wentzensen N, Castle PE, Schiffman M.
    Int J Cancer; 2020 Sep 15; 147(6):1612-1620. PubMed ID: 32141607
    [Abstract] [Full Text] [Related]

  • 48. [Colposcopy and cervical biopsy in patients with routine Papanicolaou smear].
    Milla Villeda RH, Alvarado Zaldívar G, Sánchez Anguiano LF, Barrera Tovar M, Vázquez Arreola I.
    Ginecol Obstet Mex; 1997 Jun 15; 65():235-8. PubMed ID: 9273333
    [Abstract] [Full Text] [Related]

  • 49. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C, Karlsson H, Spetz Holm AC.
    PLoS One; 2020 Jun 15; 15(7):e0235202. PubMed ID: 32614875
    [Abstract] [Full Text] [Related]

  • 50. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.
    Kitchener HC, Almonte M, Thomson C, Wheeler P, Sargent A, Stoykova B, Gilham C, Baysson H, Roberts C, Dowie R, Desai M, Mather J, Bailey A, Turner A, Moss S, Peto J.
    Lancet Oncol; 2009 Jul 15; 10(7):672-82. PubMed ID: 19540162
    [Abstract] [Full Text] [Related]

  • 51. Liquid-based cytology and conventional cervical smears: a comparison study in an Asian screening population.
    Cheung AN, Szeto EF, Leung BS, Khoo US, Ng AW.
    Cancer; 2003 Dec 25; 99(6):331-5. PubMed ID: 14681939
    [Abstract] [Full Text] [Related]

  • 52. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India.
    Arbyn M, Sankaranarayanan R, Muwonge R, Keita N, Dolo A, Mbalawa CG, Nouhou H, Sakande B, Wesley R, Somanathan T, Sharma A, Shastri S, Basu P.
    Int J Cancer; 2008 Jul 01; 123(1):153-60. PubMed ID: 18404671
    [Abstract] [Full Text] [Related]

  • 53. Positive diagnostic values and histological detection ratios from the Rotterdam cervical cancer screening programme.
    Kreuger FA, Beerman H, Nijs HG, van Ballegooijen M.
    Int J Epidemiol; 1998 Jun 01; 27(3):377-81. PubMed ID: 9698123
    [Abstract] [Full Text] [Related]

  • 54. Changes in the incidence of cervical tumours by disease stage in a cytology-based screening programme.
    Bucchi L, Mancini S, Baldacchini F, Giuliani O, Ravaioli A, Vattiato R, Falcini F, Giorgi Rossi P, Campari C, Canuti D, Di Felice E, de Bianchi PS, Ferretti S, Emilia-Romagna Region Workgroup for Cervical Screening Evaluation.
    J Med Screen; 2020 Jun 01; 27(2):96-104. PubMed ID: 31690178
    [Abstract] [Full Text] [Related]

  • 55. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
    Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG, Lörincz A, Hernández P, Salmerón J, Morelos HPV Study Collaborators.
    Salud Publica Mex; 2002 Jun 01; 44(4):335-44. PubMed ID: 12216521
    [Abstract] [Full Text] [Related]

  • 56. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.
    Kitchener HC, Almonte M, Gilham C, Dowie R, Stoykova B, Sargent A, Roberts C, Desai M, Peto J, ARTISTIC Trial Study Group.
    Health Technol Assess; 2009 Nov 01; 13(51):1-150, iii-iv. PubMed ID: 19891902
    [Abstract] [Full Text] [Related]

  • 57. Screening capacity and cost-effectiveness of the human papillomavirus test versus cervicography as an adjunctive test to Pap cytology to detect high-grade cervical dysplasia.
    Song T, Seong SJ, Lee SK, Kim BR, Ju W, Kim KH, Nam K, Sim JC, Kim TJ.
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar 01; 234():112-116. PubMed ID: 30682600
    [Abstract] [Full Text] [Related]

  • 58. Incidence of Pap test abnormalities within 3 years of a normal Pap test--United States, 1991-1998.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2000 Nov 10; 49(44):1001-3. PubMed ID: 11097139
    [Abstract] [Full Text] [Related]

  • 59. hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi).
    Carozzi FM, Iossa A, Scalisi A, Sideri M, Andersson KL, Confortini M, Del Mistro A, Maina G, Ronco G, Raggi P, Schiboni ML, Zappa M, Giorgi Rossi P.
    Epidemiol Prev; 2015 Nov 10; 39(3 Suppl 1):84-90. PubMed ID: 26405780
    [Abstract] [Full Text] [Related]

  • 60. Only a small fraction of high-grade cervical lesions are discovered after an interpretation of atypical squamous cells of undetermined significance when using imager-assisted, liquid-based papanicolaou tests and the Bethesda 2001 system.
    Khan KA, Smith DA, Thrall MJ.
    Arch Pathol Lab Med; 2013 Jul 10; 137(7):936-41. PubMed ID: 22994456
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.